Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SHAIL DALAL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1144241597
CMS profile
97415
Location
PALESTINE, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$42,682.82

87 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 2; records 51–87 of 87 matching records. This page contains 37 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SHAIL DALAL

NPI 1144241597 · CMS profile ID 97415

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

PALESTINE, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–87 of 87 matching records. This page contains 37 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1144241597?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SHAIL DALAL, NPI 1144241597, CMS profile ID 97415. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–87 of 87 matching records. This page contains 37 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1144241597?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). SHAIL DALAL, NPI 1144241597, CMS profile ID 97415. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–87 of 87 matching records. This page contains 37 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1144241597?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
SHAIL DALAL, NPI 1144241597, CMS profile ID 97415, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–87 of 87 matching records. This page contains 37 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1144241597?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

87 matching records · $42,682.82 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 87 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–87 of 87.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Myriad Genetic Laboratories, Inc. $25.0005/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937229031 CMS
Myriad Genetic Laboratories, Inc. $30.0005/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937229035 CMS
Myriad Genetic Laboratories, Inc. $569.9505/06/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937229053 CMS
Myriad Genetic Laboratories, Inc. $36.0005/06/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937229057 CMS
Myriad Genetic Laboratories, Inc. $76.6405/06/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937229061 CMS
Myriad Genetic Laboratories, Inc. $3,400.0005/05/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937229023 CMS
Myriad Genetic Laboratories, Inc. $76.6405/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937229039 CMS
Myriad Genetic Laboratories, Inc. $195.0005/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937229043 CMS
Myriad Genetic Laboratories, Inc. $32.2105/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937229049 CMS
Myriad Genetic Laboratories, Inc. $121.6305/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937237235 CMS
E.R. Squibb & Sons, L.L.C. $14.6404/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932655321 CMS
AstraZeneca Pharmaceuticals LP $231.8504/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914868653 CMS
AstraZeneca Pharmaceuticals LP $52.2604/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914910543 CMS
AstraZeneca Pharmaceuticals LP $6.6704/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915299361 CMS
Daiichi Sankyo Inc. $550.0004/12/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930866673 CMS
BeiGene USA, Inc. $937.5004/08/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940790227 CMS
Myriad Genetic Laboratories, Inc. $1,700.0003/29/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937237215 CMS
Myriad Genetic Laboratories, Inc. $425.0003/11/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937234467 CMS
Myriad Genetic Laboratories, Inc. $17.8903/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937246759 CMS
Myriad Genetic Laboratories, Inc. $425.0002/19/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937234463 CMS
Incyte Corporation $50.0002/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943012469 CMS
Incyte Corporation $21.2802/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943012473 CMS
Incyte Corporation $9.0002/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943012475 CMS
Incyte Corporation $2,070.0002/15/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943012479 CMS
Myriad Genetic Laboratories, Inc. $637.5002/14/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937234219 CMS
Myriad Genetic Laboratories, Inc. $425.0002/14/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937234459 CMS
Myriad Genetic Laboratories, Inc. $637.5002/14/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937237211 CMS
Incyte Corporation $680.9401/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943012463 CMS
Incyte Corporation $258.7701/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943012465 CMS
Incyte Corporation $59.0001/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943012467 CMS
Incyte Corporation $38.2801/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943012471 CMS
Incyte Corporation $2,350.0001/20/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943012477 CMS
Lilly USA, LLC $100.3601/19/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918331211 CMS
Novocure GmbH $200.0001/19/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950529869 CMS
E.R. Squibb & Sons, L.L.C. $24.5101/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932655411 CMS
Myriad Genetic Laboratories, Inc. $1,700.0001/11/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937234215 CMS
Myriad Genetic Laboratories, Inc. $27.5001/11/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937234223 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $11,875.32 26
PY2020 $30,643.77 41
PY2021 $37,726.18 56
PY2022 $42,682.82 87
PY2023 $29,163.29 113
PY2024 $19,791.37 123
PY2025 $16,999.31 141

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $46,103.86 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $20,000.00 12/04/2025 Non-covered Recipient Entity
TEXAS ONCOLOGY - PALESTINE CANCER CENTER
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer No dispute reported 06/30/2026 1202527868
Principal investigator 1 AstraZeneca Pharmaceuticals LP $19,094.47 04/30/2025 Non-covered Recipient Entity
TEXAS ONCOLOGY, PA
A Phase III Randomized Double blind Multicenter Global Study of Rilvegostomig or Pembrolizumab in Combination with Platinum based Chemotherapy for the First line Treatment of Patients with Metastatic Non squamous Non small Cell Lung Cancer Whose Tumors Express PDL1 ARTEMIDE Lung03 No dispute reported 06/30/2026 1185545953
Principal investigator 1 Amgen Inc. $7,009.39 03/25/2025 Non-covered Recipient Entity
TEXAS ONCOLOGY NORTHEAST TEXAS
A Noninterventional Biomarker Study on the Molecular Evaluation of Archival Tumor Tissue in Subjects with Advanced or Metastatic Malignancies No dispute reported 06/30/2026 1246649296